FDA NDC Directory · JSON-LD · Markdown

Acamprosate Calcium

NDC 0378-6333 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Generic nameacamprosate calcium enteric-coated
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA200142
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsACAMPROSATE CALCIUM (333 mg/1)
Marketing started20140924
Package count1

External sources

Source: openFDA. Public-domain (CC0).